The global Electroencephalography Devices or EEG System market was valued at USD 1,050.48 million in 2022 and growing at a CAGR of 9.96% during the forecast period (2023 to 2028); it is expected to reach USD 1,850.84 million by 2028. The demand for EEG devices is primarily being boosted by the increasing figures of neurologic disorders such as epilepsy, stroke, coma, sleeping disorders, and others. Further, the rising adoption of advanced and innovative technologies, the increasing geriatric population, the increasing device launches & approval, and others are contributing to the overall growth of the EEG devices market during the forecast period from 2023-2028. Some of the key market players operating in the EEG devices market include Allengers, Nihon kohden corporation, Cadwell Industries, Magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others.
DelveInsight’s “Electroencephalography Devices Market Insight, Competitive Landscape and Market Forecast 2028” research report provides the current and forecasted Electroencephalography Devices market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.
Electroencephalography Devices/ EEG System Market: Overview
Electroencephalography (EEG) devices assist to identify irregularities in brain waves, or the electrical activity in the brain, which can be used to diagnose a variety of neurological conditions like epilepsy or seizures. The tool can also aid in the diagnosis of encephalitis, brain tumors, dementia, sleep disorders, Alzheimer’s disease, and other conditions.
To provide a better understanding of the market dynamics, DelveInsight’s “Electroencephalography Devices Market” report provides an in-depth assessment of the market by type (EEG Equipment and EEG Accessories), Modality (Portable Device and Non-Portable Device), Application (Disease Diagnosis, Anesthesia Monitoring, Sleep Monitoring, and Others), and End-User (Hospitals, Home Healthcare, Diagnostic Centers, and Others). In the modality segment of the EEG System market, the portable devices’ category is expected to amass a significant revenue share in the year 2022 owing to the advantages offered by these devices. For instance, after any injury or disease, patients need continuous monitoring of the brain and its activity. In such cases, portable EEG devices are advised to measure the physiological condition of the brain. Further, the increasing cases of traumatic brain injury, product launches, approval, mergers, and others will increase the demand for portable EEG devices.
Electroencephalography Devices Market Analysis
Due to a number of variables, and the rising frequency of various neurological conditions including epilepsy, sclerosis, dementia, and others, the market for EEG devices is experiencing an increase in product demand. Globally, an estimated 5 million people were diagnosed with epilepsy each year. The increasing cases of epilepsy will need an EEG device to diagnose epilepsy, as the device records activity from the cortex and the deeper brain structures. Similarly, in 2022, there were 12.2 million new strokes per year around the world, which is 1 in every 3 seconds. Furthermore, a stroke occurs when the blood supply to the brain is reduced, which prevents brain tissue from getting oxygen and nutrients. Thus, the increasing number of stroke cases will increase the demand for EEG devices, as these devices aid in the diagnosis of such neurological diseases. Overall, the rising neurological conditions are expected to immensely influence the EEG device market during the forecast period from 2023-2028. However, the presence of alternative devices is anticipated to hamper the EEG device market growth.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight @ Electroencephalography Devices Types and Emerging Products
Electroencephalography Devices – Global Market Assessment and Forecast
Among all the regions, North America is estimated to account for the largest share of the EEG device market in the year 2022. The market is expected to grow immensely owing to the rising prevalence of sleep disorders, the growing cases of Alzheimer’s disease, the increasing cases of road accidents, and others. Moreover, the increasing geriatric population, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices is further expected to drive the market growth in this region.
As per the CDC (2022), by 2040, the number of older adults in the United States is expected to reach 80.8 million. By 2060, it will reach 94.7 million, and older adults will make up nearly 25% of the US population. Thus, Due to the fact that elderly patients may need to use EEG devices for ongoing monitoring of their brain activity in order to diagnose any chronic changes in their brains and to prevent stroke or other potentially fatal conditions, the growing geriatric population in the US will consequently increase the EEG devices demand. In addition to the aforementioned factors, strategic actions including product launches and approvals, mergers, acquisitions, and collaborations will also help to increase the Electroencephalography Devices market growth in the region.
Interested in knowing how the EEG System market will grow by 2028? Click to get a snapshot @ Electroencephalography Devices Market Trends and Developments
Electroencephalography Devices Market – Key Developments and Breakthroughs
Over the years, the Electroencephalography Devices market has evolved significantly, owing to the active participation of global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered in the domain.
Some of the major advancements in the Electroencephalography Devices market in recent years include –
- In January 2023, Compumedics Limited received FDA approval for the OKTI system. The Okti System is intended for use in the diagnosis of various neurological disorders, a deep understanding of patient care, and also be used for routine and long Term EEG. The Okti is a simple, portable, wireless system.
- In January 2023, Bioserenity received FDA approval for Neuronaute with IceCap 2 & IceCap 2 Small. Neuronaute with IceCap2 & IceCap 2 Small, is a system intended to acquire, display, store, archive, and periodically transmit EEG signals from the brain using a full montage array to enable review at a physician’s office, hospital, or other remote locations.
- In December 2022, Natus Medical completed the previously announced acquisition with Micromed Holdings. Natus Neuro Team will work closely with Micromed management to build upon the Micromed momentum in the European epilepsy market and the emerging presence of Moberg in the ICU.
- In December 2021, WAVi Co. received FDA approval for WAVi SCAN EEG System and Accessories. WAVi SCAN is intended for the acquisition, display, and storage of electrical activity in the patient’s brain, including electroencephalograph (EEG) and event-related potentials (ERP) obtained by placing two or more electrodes on the head to aid in diagnosis.
Learn more about major clinical and commercial development in the EEG System Market @ Electroencephalography Devices Market – Clinical and Commercial Development Activities
Key Companies in the Electroencephalography Devices Market
Globally, some of the leading Electroencephalography Devices companies actively working in the market include Allengers, Nihon kohden corporation, cadwell industries, magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others. Owing to the rising demand and favorable growth opportunities for revenue generation, several new players are anticipated to enter the market, thereby leading to high competitiveness in the domain.
Learn how new players’ entries will transform the EEG System market dynamics in the coming years @ Electroencephalography Devices Competitive Landscape
Scope of the Electroencephalography Devices Market Report:
- Study Period – 2020-2028
- Geography Covered – North America, Europe, Asia-Pacific, and Rest of the World
- Electroencephalography Devices Market Assessment –
-
-
- By Type – EEG Equipment and EEG Accessories
- Modality – Portable Device and Non-Portable Device
- Application – Disease Diagnosis, Anesthesia Monitoring, Sleep Monitoring, and Others
- End-User – Hospitals, Home Healthcare, Diagnostic Centers, and Others
-
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views
Table of Content
| 1 | Report Introduction |
| 2 | Executive Summary |
| 3 | Regulatory and Patent Analysis in the EEG System Market |
| 4 | Electroencephalography Devices Market Key Factors Analysis |
| 5 | Electroencephalography Devices Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on the Electroencephalography Devices Market |
| 7 | Electroencephalography Devices Market Layout |
| 8 | Electroencephalography Devices Companies Share Analysis – Top 3–5 Companies |
| 9 | Electroencephalography Devices Companies and Major Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views on EEG System Market |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Reach out to us to get a more detailed overview of the market @ Electroencephalography Devices Market Insights and Competitive Landscape
Other Trending Healthcare Reports by DelveInsight:
KRAS Inhibitors Market | Abetalipoproteinemia Market | Cartilage Diseases Market | Genital Herpes Market | Childhood Atropine For Myopia Progression Market | Germ Cell Tumor Market | Gestational Diabetes Market | Hypercoagulability Market | Lipodystrophy Market | Bronchial Spasm Market | Meningioma Market | Necrotizing Enterocolitis Market Hyperhidrosis Market |Bacterial Meningitis Market | Anaphylaxis Market | Neurostimulation Devices Market | Intracranial Pressure Monitoring Devices Market | Acute Pharyngitis Market | Hepatitis B Virus Market | Thymic Carcinoma Market | Bladder Cancer Market | Spasticity Market | Interbody Cages Market | Helicobacter Pylori Infection Market | Intravenous Immunoglobulin Market | Opioid Induced Constipation Market | Ophthalmic Imaging Equipment Market | Epilepsy Market | Pharmaceutical Consulting Companies | Acquired Immunodeficiency Syndrome Market | Image Guided Surgery Devices Market | Androgenetic Alopecia Market | Acute Lung Injury Market | Astigmatism Market | Familial Primary Pulmonary Hypertension Market | Progressive Multifocal Leukoencephalopathy Market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Leverage the potential of consulting services to overcome the competition in the highly evolving and dynamic healthcare market with Healthcare Asset Prioritization Services and Pharma and Biotech Pipeline Assessment
Contact Us
Shruti Thakur
Manager (Marketing & Branding)
info@delveinsight.com
+1(919)321-6187.